Dr. Reddy’s Laboratories has introduced 'Nivorz', a biosimilar cancer therapy, into the Indian market. The product is manufactured at the company's Hyderabad facility. Investors are assessing the move within a market valued at ₹3,900 cro...
Laurus Labs reported a 69% year-on-year surge in CDMO revenue for the June quarter, helping it cross the ₹1 lakh crore market capitalization milestone. Driven by strong commercial scaling, the company raised its FY27 capital spending gui...
Aurobindo Pharma has received final USFDA approval for its generic Beclomethasone Dipropionate HFA Inhalation Aerosol. This marks the company's first-ever metered-dose inhaler product, targeting a $301 million US market.